TargetMol

CL-387785

Product Code:
 
TAR-T2245
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T2245-1mg1mg£97.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2245-2mg2mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2245-5mg5mg£115.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2245-1mL1 mL * 10 mM (in DMSO)£119.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2245-10mg10mg£142.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2245-25mg25mg£213.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2245-50mg50mg£301.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2245-100mg100mg£442.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2245-500mg500mg£863.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
CL-387785(EKI785; WAY-EKI 785) is an irreversible inhibitor of EGFR?IC50? 370+/-120 pM?; is able to overcome resistance caused by the T790M mutation on a functional level.
CAS:
194423-06-8
Formula:
C18H13BrN4O
Molecular Weight:
381.233
Pathway:
Angiogenesis; Tyrosine Kinase/Adaptors; JAK/STAT signaling
Purity:
0.9668
SMILES:
CC#CC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1
Target:
EGFR

References

1. Discafani CM, et al. Biochem Pharmacol. 1999, 57(8), 917-925. 2. William E, et al. Kidney International. 2000, 57(1), 33-40. 3. Hama T, et al. Clin Exp Metastasis. 2012, 29(1), 19-25. 4. Kancha RK, et al. PloS ONE. 2011, 6(10), e26760. 5. Roberts RB, et al. Proc Natl Acad Sci. 2002, 99(3), 1521-1526.